Qube Blog
Welcome to the Qube Blog, where we share the latest insights from the worlds of healthcare, biotechnology and technology innovation.
Latest Articles
Sylentis announces results of its Phase III Clinical Trial HELIX in Dry Eye Syndrome
Sylentis a company fo the PharmaMar group with offices and laboratories at QUBE announces results of its Phase III Clinical Trial HELIX with tivanisiran (SYL1001) for the treatment of Dry Eye Syndrome. The HELIX trial has demonstrated an improvement (p=0.035) in the...
read more
Agrenvec broadens its portfolio of products and services
Agrenvec, a company based at QUBE, broadens its portfolio of policlonal antibodies and recombinant proteins expressed in plants. Agreenvec is focused in the expression and purificacion of recombinant proteins in plants. Expresion in plants allows........
read more